-transparent.png){kind=logo}
We describe here the generation and characterization of a human monoclonal IgG antibody (UL/F14) specific for HLA-B12. The antibody is suitable for complement-dependent lysis on lymphoblastoid cell lines and stimulated peripheral blood mononuclear cells. UL/F14 competes for antigen binding with an HLA-B12 human monoclonal IgM antibody and with a specific alloantiserum. Protein chemistry shows that the monoclonal antibody UL/F14 can precipitate solubilized HLA-B12 molecules.
Related Publications
K Siemoneit, and
A Wölpl, and
S Wegener, and
M Ernst, and
H H Sonneborn, and
S F Goldmann
August 2003,
Hybridoma and hybridomics,
K Siemoneit, and
A Wölpl, and
S Wegener, and
M Ernst, and
H H Sonneborn, and
S F Goldmann
June 2007,
Hybridoma (2005),
K Siemoneit, and
A Wölpl, and
S Wegener, and
M Ernst, and
H H Sonneborn, and
S F Goldmann
April 2008,
Hybridoma (2005),
K Siemoneit, and
A Wölpl, and
S Wegener, and
M Ernst, and
H H Sonneborn, and
S F Goldmann
May 2007,
Clinical chemistry,
K Siemoneit, and
A Wölpl, and
S Wegener, and
M Ernst, and
H H Sonneborn, and
S F Goldmann
February 1993,
Tissue antigens,
K Siemoneit, and
A Wölpl, and
S Wegener, and
M Ernst, and
H H Sonneborn, and
S F Goldmann
January 1987,
The International journal of biological markers,
K Siemoneit, and
A Wölpl, and
S Wegener, and
M Ernst, and
H H Sonneborn, and
S F Goldmann
February 2018,
Scientific reports,
K Siemoneit, and
A Wölpl, and
S Wegener, and
M Ernst, and
H H Sonneborn, and
S F Goldmann
February 2006,
Hybridoma (2005),
K Siemoneit, and
A Wölpl, and
S Wegener, and
M Ernst, and
H H Sonneborn, and
S F Goldmann
January 2011,
Immunobiology,
K Siemoneit, and
A Wölpl, and
S Wegener, and
M Ernst, and
H H Sonneborn, and
S F Goldmann
March 1992,
Hypertension (Dallas, Tex. : 1979),
